This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Correction · September 15, 2026
We added a preserved FDA-hosted product label to support the product-specific label account. Prior profile versions retain their original citations. 2
What this version reported
The cited DailyMed label identifies Lixisenatide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.↗
Organizations named in cited records:
- U.S. National Library of Medicine↗
Sources for this version
- 1SOLIQUA 100/33 (insulin glargine and lixisenatide) injection · SPL version 25 · published 2026-03-20 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 2ADLYXIN, revised November 2024: U.S. prescribing information ↗
U.S. Food and Drug Administration · Official source · Source checked September 15, 2026